Aarkstore - Metastatic Biliary Tract Cancer - Pipeline Review, H2 2014 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Aarkstore - Metastatic Biliary Tract Cancer - Pipeline Review, H2 2014

Description:

This report provides comprehensive information on the therapeutic development for Metastatic Biliary Tract Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Browse full report @ – PowerPoint PPT presentation

Number of Views:22

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Metastatic Biliary Tract Cancer - Pipeline Review, H2 2014


1
Metastatic Biliary Tract Cancer - Pipeline
Review, H2 2014
Category  Healthcare
2
Summary
  • Metastatic Biliary Tract Cancer - Pipeline
    Review, H2 2014, provides an overview of the
    Metastatic Biliary Tract Cancers therapeutic
    pipeline.This report provides comprehensive
    information on the therapeutic development for
    Metastatic Biliary Tract Cancer, complete with
    comparative analysis at various stages,
    therapeutics assessment by drug target, mechanism
    of action (MoA), route of administration (RoA)
    and molecule type, along with latest updates, and
    featured news and press releases. It also reviews
    key players involved in the therapeutic
    development for Metastatic Biliary Tract Cancer
    and special features on late-stage and
    discontinued projects.

Browse Complete Report - http//www.aarkstore.com/
healthcare/89680/metastatic-biliary-tract-cancer-p
ipeline-review-h2-2014
3
Scope
  • - The report provides a snapshot of the global
    therapeutic landscape of Metastatic Biliary Tract
    Cancer- The report reviews key pipeline products
    under drug profile section which includes,
    product description, MoA and RD brief, licensing
    and collaboration details other developmental
    activities - The report reviews key players
    involved in the therapeutics development for
    Metastatic Biliary Tract Cancer and enlists all
    their major and minor projects- The report
    summarizes all the dormant and discontinued
    pipeline projects - A review of the Metastatic
    Biliary Tract Cancer products under development
    by companies and universities/research institutes
    based on information derived from company and
    industry-specific sources- Pipeline products
    coverage based on various stages of development
    ranging from pre-registration till discovery and
    undisclosed stages

4
Reasons to buy
  • - Provides strategically significant competitor
    information, analysis, and insights to formulate
    effective RD development strategies- Identify
    emerging players with potentially strong product
    portfolio and create effective counter-strategies
    to gain competitive advantage- Develop strategic
    initiatives by understanding the focus areas of
    leading companies- Identify and understand
    important and diverse types of therapeutics under
    development for Metastatic Biliary Tract Cancer-
    Plan mergers and acquisitions effectively by
    identifying key players of the most promising
    pipeline- Devise corrective measures for
    pipeline projects by understanding Metastatic
    Biliary Tract Cancer pipeline depth and focus of
    Indication therapeutics

5
Table of Content
  • Introduction 5Global Markets Direct Report
    Coverage 5Metastatic Biliary Tract Cancer
    Overview 6Therapeutics Development 7Pipeline
    Products for Metastatic Biliary Tract Cancer -
    Overview 7Pipeline Products for Metastatic
    Biliary Tract Cancer - Comparative Analysis
    8Metastatic Biliary Tract Cancer - Therapeutics
    under Development by Companies 9Metastatic
    Biliary Tract Cancer - Pipeline Products Glance
    10Clinical Stage Products 10Metastatic Biliary
    Tract Cancer - Products under Development by
    Companies 11Metastatic Biliary Tract Cancer -
    Companies Involved in Therapeutics Development
    12AstraZeneca PLC 12GlaxoSmithKline plc
    13Novartis AG 14OncoTherapy Science, Inc. 15

6
List of Tables
  • Number of Products under Development for
    Metastatic Biliary Tract Cancer, H2 2014 7Number
    of Products under Development for Metastatic
    Biliary Tract Cancer - Comparative Analysis, H2
    2014 8Number of Products under Development by
    Companies, H2 2014 9Comparative Analysis by
    Clinical Stage Development, H2 2014 10Products
    under Development by Companies, H2 2014
    11Metastatic Biliary Tract Cancer - Pipeline by
    AstraZeneca PLC, H2 2014 12Metastatic Biliary
    Tract Cancer - Pipeline by GlaxoSmithKline plc,
    H2 2014 13Metastatic Biliary Tract Cancer -
    Pipeline by Novartis AG, H2 2014 14Metastatic
    Biliary Tract Cancer - Pipeline by OncoTherapy
    Science, Inc., H2 2014 15Assessment by
    Monotherapy Products, H2 2014 16Assessment by
    Combination Products, H2 2014 17Number of
    Products by Stage and Target, H2 2014 19Number
    of Products by Stage and Mechanism of Action, H2
    2014

7
List of Figures
  • Number of Products under Development for
    Metastatic Biliary Tract Cancer, H2 2014 7Number
    of Products under Development for Metastatic
    Biliary Tract Cancer - Comparative Analysis, H2
    2014 8Number of Products under Development by
    Companies, H2 2014 9Comparative Analysis by
    Clinical Stage Development, H2 2014 10Assessment
    by Monotherapy Products, H2 2014 16Number of
    Products by Top 10 Targets, H2 2014 18Number of
    Products by Stage and Top 10 Target, H2 2014
    19Number of Products by Top 10 Mechanism of
    Actions, H2 2014 20Number of Products by Stage
    and Top 10 Mechanism of Actions, H2 2014
    21Number of Products by Stage and Top 10 Routes
    of Administration, H2 2014 22Number of Products
    by Top 10 Molecule Types, H2 2014 23Number of
    Products by Stage and Top 10 Molecule Types, H2
    2014 24

8
Related Reports
  • Pancreatitis Global Clinical Trials Review, H2,
    2014
  • Onchocerciasis (River Blindness) Global Clinical
    Trials Review, H2, 2014
  • Pediculosis (Head Lice Infestation) Global
    Clinical Trials Review, H2, 2014
  • Severe Acute Respiratory Syndrome (SARS)
    Coronavirus Infection Global Clinical Trials
    Review, H2, 2014
  • Urinary Tract Infections Global Clinical Trials
    Review, H2, 2014
  • Vulvovaginal Candidiasis Global Clinical Trials
    Review, H2, 2014
  • Pleural Effusion Global Clinical Trials Review,
    H2, 2014
  • Febrile Neutropenia Global Clinical Trials
    Review, H2, 2014
  • Respiratory Depression Global Clinical Trials
    Review, H2, 2014

9
  • Metastatic Biliary Tract Cancer - Pipeline
    Review, H2 2014
  • Published Dec 2014 48 Pages
  • Metastatic Biliary Tract Cancer - Pipeline
    Review, H2 2014, provides an overview of the
    Metastatic Biliary Tract Cancers therapeutic
    pipeline.
  • Price

Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence 6000
10
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog
  • http//www.aarkstore.com/blog/
  • Conference
  • http//conference.aarkstore.com/
  • News
  • http//www.aarkstore.com/news
About PowerShow.com